🇬🇧 United Kingdom Country × Condition
malignant neoplasm Clinical Trials in United Kingdom
Active clinical trials for malignant neoplasm with research sites in United Kingdom. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇬🇧 United Kingdom
Active Trials in United Kingdom (2)
NCT05770102 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → NCT05770037 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
Enrollment
30 pts
Country
🇬🇧 United Kingdom
Cancer Research UK
View Trial → Frequently Asked Questions
How many malignant neoplasm clinical trials are active in United Kingdom?
There are currently 2 active clinical trials for malignant neoplasm with sites in United Kingdom, of which 2 are actively recruiting patients.
How can I join a malignant neoplasm clinical trial in United Kingdom?
To join a malignant neoplasm clinical trial in United Kingdom, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United Kingdom directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are malignant neoplasm trials in United Kingdom?
Active malignant neoplasm trials in United Kingdom span Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology